(RN/AYU)
As shown in Figure 6A , GSH levels decreased to 2540% of control cells after AQ-QI or DEAQ-QI treatment, while the intracellular GSSG concentrations did not increase correspondingly, but decreased to approximately 4580% ( Figure 6B )
With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month, subject to caps
By activating both receptor systems, tirzepatide appears to produce greater weight loss than GLP1 agonists alone
In contrast, GSH depletion drives M1 polarization, resulting in heightened secretion of pro-inflammatory cytokines, including TNF-, IL-6, and IL-1 (Kwon et al., 2019)